BioMed Posts 18.3 Percent Revenue Increase for 2012Thursday, February 7, 2013
Locally based real estate investment firm BioMed Realty Trust Inc. saw revenue rise 23.9 percent for its fourth quarter ending Dec. 31, and 18.3 percent for the full year 2012.
A company statement said the San Diego-based real estate investment trust posted total revenue of $138.8 million for the quarter and $518.2 million for the year.
The company reported a 2012 net loss attributable to common stockholders of $2.8 million, compared with net income of $26 million in 2011. The net loss for the year included acquisition-related expenses of $13.1 million.
Officials reported that funds from operations, a supplemental industry-recognized metric gauging the performance of real estate portfolios, rose 27 percent for the quarter, to $59.5 million. For the full year, funds from operations increased 18 percent, to $206.5 million.
BioMed focuses on life sciences real estate and trades under the symbol BMR on the New York Stock Exchange.
— SDBJ Staff Report